Risk Of Developing Liver Cancer After HCV Treatment

Sunday, November 15, 2015

Weekend Updates: Series Of 5-minute Daily Clips From The Liver Meeting 2015


Series Of 5-minute Daily Clips From The Liver Meeting 2015

Hello everyone, The Liver Meeting is in full swing with new clinical data on approved medicines and investigational therapies for the treatment of chronic hepatitis C, so much to read, so little time, so confusing.

If spending hours online sifting through conference coverage is too overwhelming, take a look see at "Practice Point CME" for a series of five minute daily video clips highlighting this months liver meeting. Although these learning activities are aimed at medical professionals, this CME is patient friendly.

Already registered? Start with Saturday's video, if not follow the steps provided below to get you started.


Navigating The Activity 

1 - A quick free registration is required (click other when in doubt

2 - After registering simply click on the "daily video."

3 - Follow the instructions after pop-up appears: Review the required information (use scroll bar on the right)and then click the "Access Video" button to access this activity

4 - No need to click on "Claim Credit"


Independent Coverage from The Liver Meeting 2015*
Certified CME/CNE/CPE Activity - Clinical Clips
Advances in hepatitis research often unfold rapidly. In order to deliver state-of-the-art care, healthcare providers who manage this patient population must stay abreast of data emerging from the major conferences. These educational Clinical Clips will spotlight the latest advances in the prevention and treatment of hepatitis C through a series of daily, ‘what you need to know in 5-minutes’ videos each day from The Liver Meeting 2015* in San Francisco, California.

*This coverage is not sanctioned by the conference organizers and is not an official part of the conference proceedings of The Liver Meeting, American Association for the Study of Liver Diseases (AASLD).

Additional Links 
AASLD - Conference Coverage
Indexed by pharmaceutical company:
Follow the links and review the latest data on chronic hepatitis C coming out of this months liver meeting. *A link to "Practice Point CME" will be included as well.

No comments:

Post a Comment